Old Web
English
Sign In
Acemap
>
authorDetail
>
Iris Benz-Rüd
Iris Benz-Rüd
Everolimus
Renal cell carcinoma
Gastroenterology
Hazard ratio
Internal medicine
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).
2021
Cancers
Philip Zeuschner
Sebastian Hölters
Michael Stöckle
Barbara Seliger
Anja Mueller
Hagen S. Bachmann
Viktor Grünwald
Daniel C. Christoph
Arnulf Stenzl
Marc-Oliver Grimm
Fabian Brüning
Peter J. Goebell
Marinela Augustin
Frederik C. Roos
Johanna Harde
Iris Benz-Rüd
Michael Staehler
Kerstin Junker
Show All
Source
Cite
Save
Citations (0)
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
2020
International Journal of Cancer
Michael Staehler
Michael Stöckle
Daniel C. Christoph
Arnulf Stenzl
Karin Potthoff
Marc-Oliver Grimm
Dunja Klein
Johanna Harde
Fabian Brüning
Peter J. Goebell
Marinela Augustin
Frederik C. Roos
Iris Benz-Rüd
Norbert Marschner
Viktor Grünwald
Show All
Source
Cite
Save
Citations (1)
1
map